U.S. President Trump: FDA has approved chloroquine for use in COVID-19

Market news

19 March 2020

U.S. President Trump: FDA has approved chloroquine for use in COVID-19

Hydroxychloroquine (MYL) will be available immediately to help fight against COVID-19 as a therapy
Clinical trials are already underway for new therapies
Vaccine candidate was launched in record time; long-testing is required to make sure it is safe
Also mentions Regeneron and Gilead therapies

USD/JPY: Should and will be lower – Westpac

Coronavirus: Recession in virtually all G10 countries – Rabobank

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.